COVID-19 in Pediatrics: A discussion of current variants, treatments, and vaccinations

August 11, 2021

The purpose of this activity is to provide pediatric-focused education designed to increase knowledge and improve patient care skills.  Following this presentation, the audience will gain knowledge about pediatric COVID-19 complications (MIS-C), pediatric COVID-19 treatment options, updated information regarding the COVID-19 variants and pediatric vaccinations.  

Target Audience

  • Nurses
  • Pharmacists
  • Physicians

Learning Objectives

  1. Review the pathophysiology of COVID-19 in pediatrics
  2. Review background on current treatments for COVID-19 and MIS-C
  3. Review the EUA drug approvals and associated literature to identify high risk patients most likely to benefit from therapy
  4. Identify new variant and mutations and how the mutations can affect pediatric patients
  5. Review the current information regarding pediatric COVID-19 vaccines
  6. Review the current information in the literature regarding COVID-19 and the pediatric population

Additional Information

AttachmentSize
PDF icon Helpful Tips for Users - Vizient CE System.pdf134.66 KB
File Information for CE Credit - COVID-19 in Pediatrics.docx125.97 KB
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 General CE – Attendance
Course opens: 
08/11/2021
Course expires: 
09/26/2021
Event starts: 
08/11/2021 - 1:30pm CDT
Event ends: 
08/11/2021 - 2:30pm CDT
Add to calendar: 
Live via webinar
United States
Relevant financial relationships: Planning committee members and presenters have nothing to disclose.
Presenters will discuss off-label and investigative use of drugs
 
Planning committee members
 
Emily Diehl, PharmD, BCPPS
Pharmacy Executive Director
Vizient Pharmacy Advisory Services
Vizient, Inc.
 
Mandy Slinde, PharmD, BCPPS
Pharmacy Executive Director
Vizient, Inc.
 
Joseph Geskey, DO, MBA, MS-PopH
Principal, Data Science & Member Insights
Vizient, Inc.
 
Jim Lichauer, PharmD, BCPS
PI Program Director, Pharmacy
Vizient, Inc.
 
Gretchen Brummel, PharmD, BCPS
Pharmacy Executive Director
Vizient Center for Pharmacy Practice Excellence
Vizient, Inc.
 
Lindsay Mayer, MSN, RN, CPHQ (nurse planner)
Senior Director, PI Programs
Vizient, Inc.
 
Course reviewers
 
Jim Lichauer, PharmD, BCPS
PI Program Director, Pharmacy
Vizient, Inc.
 
Lindsay Mayer, MSN, RN, CPHQ (nurse planner)
Senior Director, PI Programs
Vizient, Inc.
 
Presenters
 
Emily Diehl, PharmD, BCPPS
Pharmacy Executive Director
Vizient Pharmacy Advisory Services
Vizient, Inc.
 
Mandy Slinde, PharmD, BCPPS
Pharmacy Executive Director
Vizient, Inc.
 
Joseph Geskey, DO, MBA, MS-PopH
Principal, Data Science & Member Insights
Vizient, Inc.
Joint Accreditation Statement:
 
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
____________________________________________
 
Designation Statement:
 
NURSING
This activity is designated for 1.00 contact hours.
 
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-0000-21-174-L01-P
PHYSICIAN
Vizient, Inc. designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 General CE – Attendance
Please login or register to take this course.